Across the nutra-verse: Top news from around the world (Feb 25)

By Stephen Daniells contact

- Last updated on GMT

© Getty Images / denphumi
© Getty Images / denphumi
It’s a global industry and there’s a lot happening. We know it’s not always easy keeping up with everything that’s happening around the world. The answer? Our weekly round-up of key news from across the globe.


60% of multi-ingredient pre-workout supplements use proprietary blends of ingredients

According to a new survey of top-selling multi-ingredient pre-workout supplements (MIPS), almost 60% included at least one proprietary blend with 14 different ingredients.

The data also indicated that 44% of all ingredients were included in products as part of a proprietary blend with undisclosed amounts of each ingredient.

“[W]hile FDA regulations mandate that all ingredients in a blend be listed in descending order of predominance by weight, it is difficult to determine whether individual ingredients in a proprietary blend are included in doses sufficient to elicit ergogenic effects,”​ reported Andrew Jagim from the Mayo Clinic Health System, Patrick Harty from Lindenwood University, and Clayton Camic from Northern Illinois University

The most prevalent ingredients used in the pre-workout supplements analyzed were:
Beta-alanine (87% of all products, with the average dose of 2.0 g),
Caffeine (86% of products with an average dose of 254 mg),
Citrulline (71% of products, average dose of 4.0 g),
Tyrosine (63%, average dose of 348 mg),
Taurine (51%, 1.3 g average dose), and
Creatine (49%, with an average dose of 2.1 g).

“It is worth noting that the average amounts of certain ingredients do not appear to align with the clinically-supported dosing recommendations for beta-alanine, caffeine, citrulline, creatine, or arginine,”​ stated the researchers.

“Because pre-workout supplements provide a variety of ingredients to the consumer in a single formulation, it is vital that ingredients be included at efficacious doses as this ultimately determines the long-term ergogenic potential.”

For more on this from NutraIngredients-USA, please click HERE​.


DSM Venturing invests in skin microbiome player

Royal DSM’s venture capital arm announced investment in Belgium-based life sciences company S-Biomedic, to enable the firm to “rapidly progress their portfolio of products and enter into development and commercialization agreements with leading dermatological and cosmetic brands.”

Rishabh Pande, vice president marketing and innovation personal care and aroma at DSM, stated: “With its long-established expertise in skin biology and in-depth knowledge in the field of epidermal science DSM is well placed to extend its research and innovation focus on the skin microbiome.

“We have already made encouraging discoveries about how skin actives in our existing product portfolio work on the skin and scalp microbiome. Through this investment, we hope to foster further innovation in the field.”

For more on this, please click HERE​.


Surging hemp demand in China

China Health Industries Holdings saw its Q2 revenue jump 50% year-on-year, with the growth attributed to strong sales of its new hemp derivative products, including health foods and cosmetics.

Xin Sun, the company’s CEO, told NutraIngredients-Asia​: “Currently, we have developed about 50 products, we will introduce new products every month and we are in the midst of designing the product packaging. And so, we will focus on producing health products that are made from hemp.

“We are considered the firm which produces the most variety of hemp derivative products in China, and we have our own patents…Previously, we have also participated in many conferences, such as those in Harbin, and also those which are nationally recognised and we have promoted products we have developed in these conferences

“This have helped garner public attention, which explains the sales increment,”​ Sun said.

Related news

Show more